143 related articles for article (PubMed ID: 20799046)
41. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.
Wang S; Kim S; Chawla S; Wolf RL; Knipp DE; Vossough A; O'Rourke DM; Judy KD; Poptani H; Melhem ER
AJNR Am J Neuroradiol; 2011 Mar; 32(3):507-14. PubMed ID: 21330399
[TBL] [Abstract][Full Text] [Related]
42. Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas.
Yoo RE; Choi SH; Cho HR; Kim TM; Lee SH; Park CK; Park SH; Kim IH; Yun TJ; Kim JH; Sohn CH; Han MH; Chang KH
J Magn Reson Imaging; 2013 Oct; 38(4):852-60. PubMed ID: 23390061
[TBL] [Abstract][Full Text] [Related]
43. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade.
Jackson A; Kassner A; Annesley-Williams D; Reid H; Zhu XP; Li KL
AJNR Am J Neuroradiol; 2002 Jan; 23(1):7-14. PubMed ID: 11827869
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
45. The striate sign: peritumoural perfusion pattern of infiltrative primary and recurrent gliomas.
Blasel S; Franz K; Mittelbronn M; Morawe G; Jurcoane A; Pellikan S; Zanella F; Hattingen E
Neurosurg Rev; 2010 Apr; 33(2):193-203; discussion 203-4. PubMed ID: 20195675
[TBL] [Abstract][Full Text] [Related]
46. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
Tsien C; Galbán CJ; Chenevert TL; Johnson TD; Hamstra DA; Sundgren PC; Junck L; Meyer CR; Rehemtulla A; Lawrence T; Ross BD
J Clin Oncol; 2010 May; 28(13):2293-9. PubMed ID: 20368564
[TBL] [Abstract][Full Text] [Related]
47. Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions.
Lee EJ; Ahn KJ; Lee EK; Lee YS; Kim DB
Clin Radiol; 2013 Dec; 68(12):e689-97. PubMed ID: 23969153
[TBL] [Abstract][Full Text] [Related]
48. Preoperative relative cerebral blood volume analysis in gliomas predicts survival and mitigates risk of biopsy sampling error.
McCullough BJ; Ader V; Aguedan B; Feng X; Susanto D; Benkers TL; Henson JW; Mayberg M; Cobbs CS; Gwinn RP; Monteith SJ; Newell DW; Delashaw J; Fouke SJ; Rostad S; Keogh BP
J Neurooncol; 2018 Jan; 136(1):181-188. PubMed ID: 29098571
[TBL] [Abstract][Full Text] [Related]
49. Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI.
Holmes TM; Petrella JR; Provenzale JM
AJR Am J Roentgenol; 2004 Nov; 183(5):1247-52. PubMed ID: 15505287
[TBL] [Abstract][Full Text] [Related]
50. Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes.
Mangla R; Ginat DT; Kamalian S; Milano MT; Korones DN; Walter KA; Ekholm S
J Neurooncol; 2014 Jan; 116(2):325-31. PubMed ID: 24178441
[TBL] [Abstract][Full Text] [Related]
51. Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors.
Bulakbasi N; Kocaoglu M; Farzaliyev A; Tayfun C; Ucoz T; Somuncu I
AJNR Am J Neuroradiol; 2005 Oct; 26(9):2187-99. PubMed ID: 16219821
[TBL] [Abstract][Full Text] [Related]
52. Perfusion MR imaging: moving forward.
Sorensen AG
Radiology; 2008 Nov; 249(2):416-7. PubMed ID: 18936306
[No Abstract] [Full Text] [Related]
53. Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume.
Wagner M; Nafe R; Jurcoane A; Pilatus U; Franz K; Rieger J; Steinbach JP; Hattingen E
J Neurooncol; 2011 Jul; 103(3):663-72. PubMed ID: 21061143
[TBL] [Abstract][Full Text] [Related]
54. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.
Jain R; Poisson L; Narang J; Gutman D; Scarpace L; Hwang SN; Holder C; Wintermark M; Colen RR; Kirby J; Freymann J; Brat DJ; Jaffe C; Mikkelsen T
Radiology; 2013 Apr; 267(1):212-20. PubMed ID: 23238158
[TBL] [Abstract][Full Text] [Related]
55. Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation?
Hakyemez B; Yildirim N; Erdoğan C; Kocaeli H; Korfali E; Parlak M
Neuroradiology; 2006 Oct; 48(10):695-702. PubMed ID: 16896907
[TBL] [Abstract][Full Text] [Related]
56. Meta-analysis of peritumoural rCBV values derived from dynamic susceptibility contrast imaging in differentiating high-grade gliomas from intracranial metastases.
Liang R; Wang X; Li M; Yang Y; Luo J; Mao Q; Liu Y
Int J Clin Exp Med; 2014; 7(9):2724-9. PubMed ID: 25356131
[TBL] [Abstract][Full Text] [Related]
57. Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.
Jabehdar Maralani P; Melhem ER; Wang S; Herskovits EH; Voluck MR; Kim SJ; Learned KO; O'Rourke DM; Mohan S
Eur Radiol; 2015 Sep; 25(9):2738-44. PubMed ID: 25680731
[TBL] [Abstract][Full Text] [Related]
58. Correlation of MR relative cerebral blood volume measurements with cellular density and proliferation in high-grade gliomas: an image-guided biopsy study.
Price SJ; Green HA; Dean AF; Joseph J; Hutchinson PJ; Gillard JH
AJNR Am J Neuroradiol; 2011 Mar; 32(3):501-6. PubMed ID: 21163880
[TBL] [Abstract][Full Text] [Related]
59. Increased relative cerebral blood volume (rCBV) in brain lymphoma.
Dandois V; De Coene B; Laloux P; Godfraind C; Cosnard G
J Neuroradiol; 2011 Jul; 38(3):191-3. PubMed ID: 20965569
[No Abstract] [Full Text] [Related]
60. Perfusion computed tomography assessments of peri-enhancing brain tissue in high-grade gliomas.
Stecco A; Fabbiano F; Amatuzzo P; Cignini E; Brambilla M; Masini L; Krengli M; Carriero A
Radiol Med; 2013 Apr; 118(3):431-43. PubMed ID: 22872457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
